Skip Navigation

Contribute to Meaningful Advances That Benefit Patients in Need

1979

Nurse’s Aide in Intensive Care Oncology Unit.

1988

Intensive Care Clinical Nurse in Oncology ICU participating in clinical trial data collection for phase I, II, and III studies.

1998

Director at several biopharmaceutical companies. Coordinated large clinical studies that spanned 6 continents, 30 countries, and 200 sites related to phase III sepsis and inflammatory disease studies.

2006

Co-founder of a specialty pharmaceutical company focusing on developing orphan indication products.

2014

Vice President of Integrated Product Development, leading a team of global regulatory affairs experts to help clients develop products more quickly and reach patients in need.

PAREXEL Named 2014 Best Performing CRO in Taiwan for Drug Development and Healthcare Industry Leadership

Company recognized by Foundation of Medical Professionals Alliance in Taiwan 

BOSTON, MA, and TAIPEI, Taiwan June 23, 2014 – PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named the 2014 Best Performing CRO in Taiwan for its innovative drug development strategies and healthcare industry leadership. PAREXEL received the award in May from the Foundation of Medical Professionals Alliance in Taiwan (FMPAT) during the Taiwan Biotechnology Trend and Challenges conference.

“PAREXEL applies its scientific expertise and innovative approaches to reducing clinical trial complexity to help create greater opportunities for clinical research in Taiwan and across the region,” said Albert Liou, PAREXEL Vice Chairman, Asia Pacific. “We appreciate this recognition of our ongoing commitment to simplifying drug development for our customers and supporting their efforts to prevent and cure disease.”

Since 1999, PAREXEL has provided drug developers in Taiwan with a broad range of clinical research and consulting services, as well as innovative technology solutions. Two years ago, the Company formed an alliance with National Taiwan University Hospital to strengthen its ability to meet customer demand for end-to-end services in this rapidly growing market.

“PAREXEL has a strong presence to support both international, multi-center trials that include APAC as well as region and country-specific needs,” said Mark A. Goldberg, M.D., President and Chief Operating Officer, PAREXEL. “With 4,400 employees in 23 locations across 12 countries in the region, PAREXEL offers an unparalleled infrastructure to support customers across the entire development continuum.”

Founded in 1992, FMPAT has united medical and health professionals, and devoted itself to the promotion of health and dignity of society and citizens in Taiwan. The foundation is a pioneer in clinical research training programs, medical ethics and related policy advocacy. For more information, visit www.mpat.org.tw.

taipei

Sign Up for Alerts

Get the latest PAREXEL career opportunities as soon as they become available.

Saved Jobs

You have not saved any jobs.

View all jobs

Recently Viewed Jobs

You have not recently viewed any jobs

View all jobs